The trademark INQORZO was filed by MyoKardia, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 12, 2020, and received one opposition filed on January 11, 2021 by Otsuka Pharmaceutical Co., Ltd. on Likelihood of confusion. the opponent was represented by A.A. THORNTON ALICANTE S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 11, 2021
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).